There were some reasons as below: (1) Recent studies found that IL-23 participated in tumor growth and metastasis by directly binding to the IL-23 receptor that is expressed on cancer cells in multiple inflammation-associated cancers, including oral cancer, lung cancer, liver cancer and colorectal cancer [16–19]. This evidence concerns the gene IL37 and lung carcinoma.